Princeton, NJ is part of our world-class bioprocess and analytical development network, focused on safe and efficient delivery of robust biologics and cell therapy manufacturing processes that maximize client value and drive a healthier world.
Our Princeton site features bioprocess, analytical and formulation development laboratories with significant development expertise, and has helped develop processes for over 100 recombinant protein products.
Service offerings include:
Additionally, this site has extensive cell culture expertise, including CHO-S, CHO-DG44, PerC.6, Cellca, Selexis, and CHOZN®.
Cell and gene therapies have been quickly gaining traction with many market approvals anticipated yearly. Speed is of the essence, which is why it’s so important to have a partner who knows what’s expected in regulated environments, has the flexibility to serve your unique needs, and can assist across your entire value chain. Thermo Fisher Scientific’s cell therapy cGMP manufacturing sites in Princeton, New Jersey and San Francisco, California have the expertise and flexibility you need to continue moving at a rapid pace.
Our Princeton, NJ site is a ~10,500 sq. ft. state-of-the-art cell therapy development and manufacturing facility for clinical and commercial manufacturing services. Services include:
The program management team at Princeton serves as the client’s main point of contact, and is responsible for communication and relationship management. Additionally, the program management team is comprised of subject matter experts (SMEs), and creates the program timeline focused on key milestones for each project.
Learn more about the specific equipment and capabilities at this site by downloading our Site Fact Sheet.